Gossamer Bio Inc. (GOSS) Misses Q1 EPS by 3c

Gossamer Bio Inc. (NASDAQ: GOSS) reported Q1 EPS of ($0.20), $0.03 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $16.96 million versus the consensus estimate of $4.71 million.

For earnings history and earnings-related data on Gossamer Bio Inc. (GOSS) click here.

You May Also Be Interested In

• Robinhood Ventures Fund II opens at $22.50, IPO at $25
• UBS Reiterates Buy Rating on Sysco (SYY) Following Trip to Company Headquarters
• Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation